Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alibaba Group (BABA) vs Johnson & Johnson (JNJ) Price & Performance

Alibaba GroupTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Alibaba Group vs Johnson & Johnson — how do they compare? Alibaba Group trades at $125.04 (market cap $308.93B), while Johnson & Johnson trades at $261.17 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 2× Alibaba Group's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.

BABAJNJ
Market Cap
$308.93B$626.09B
Volume
18,069,9386,156,228
Sector
Consumer CyclicalHealth
52-Week High
$189.34$267.24
52-Week Low
$94.83$172.78
Enterprise Value
$303.72B$654.37B
Dividend Yield
0.82%2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alibaba Group

Alibaba (BABA) trades at $124.80, down 5.69% on the day amid ongoing legal pressures and earnings misses. The stock shows bullish technical signals with strong moving average support but faces fundamental headwinds from three consecutive quarterly EPS misses. Revenue growth remains positive at $996.35 billion for 2025, with improved net income margin of 13.05%, though cash flow turned negative at -$97.16 billion due to heavy investing activity.

Despite analyst optimism with 86% buy ratings and $195 consensus target, significant legal risks from multiple class action lawsuits and recent earnings underperformance create near-term uncertainty. The 56% upside to target suggests potential value if legal and operational challenges resolve, but investors face elevated regulatory and execution risks in the Chinese market environment.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.

Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alibaba Group

Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.

Read more on BABA

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ